Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence
Bladder cancer (BLCA) is one of the most common cancers worldwide with high recurrence rate. Hence, we intended to establish a recurrence-related long non-coding RNA (lncRNA) model of BLCA as a potential biomarker based on multi-omics analysis. Multi-omics data including copy number variation (CNV)...
Guardado en:
Autores principales: | Zhipeng Xu, Hui Chen, Jin Sun, Weipu Mao, Shuqiu Chen, Ming Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5cfa0496cd654b00b08f725b529112a1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients
por: Mei Chen, et al.
Publicado: (2021) -
Expression, prognosis value, and immune infiltration of lncRNA ASB16-AS1 identified by pan-cancer analysis
por: Linyong Wu, et al.
Publicado: (2021) -
Identification of key molecular markers of acute coronary syndrome using peripheral blood transcriptome sequencing analysis and mRNA-lncRNA co-expression network construction
por: Ming Shen, et al.
Publicado: (2021) -
Characterizing the Copy Number Variation of Non-Coding RNAs Reveals Potential Therapeutic Targets and Prognostic Markers of LUSC
por: Jinfeng Ning, et al.
Publicado: (2021) -
Piwi Interacting RNAs perspectives: A new avenues in future cancer investigations
por: Pooneh Mokarram, et al.
Publicado: (2021)